Sorry, you need to enable JavaScript to visit this website.
Home
  • Careers
    • Working Here
      • Mission & Purpose
      • Culture
      • Diversity & Inclusion
      • Career Growth & Colleague Development
      • Compensation & Benefits
      • Ensuring Corporate Responsibility
    • Search Jobs
    • Student & Early Career
      • Postdoctoral Program
      • US Summer Student Worker Program
      • Opportunities for Veterans
    • Pfizer365.com
    • Our Hiring & Recruiting Process
      • Frequently Asked Questions
      • Tips for Interviewing at Pfizer
    • Connect With Us
  • Investors
    • Investors Overview
      • Why Invest / Our Story
      • Prospective Investors
      • Fact Sheet
    • Events & Presentations
    • Financials
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
      • Interactive Data Filings
    • Investor News
    • Stock Information
      • Historical Stock Chart & Data
      • Investment Calculator
      • Historical Price Lookup
      • Dividend & Split History
      • Stock FAQs
    • Governance
      • Board Committees and Charters
      • The Pfizer Board Policies
      • Corporate Governance FAQs
      • Contact Our Directors
    • Shareholder Services
      • Stock FAQs
      • Cost Basis Calculator
      • Advisory Information
  • News
    • Press Release Archive
    • Press Statements
    • Company Press Kit
    • Vaccines Press Kit
    • Get Old Press Kit
    • Pfizer Oncology Press Kit
    • Frequently Requested Info
    • Contact Media Relations
    • RA NarRAtive
  • Partners
    • Partnership Highlights
    • Events Pfizer is Attending
    • Biopharmaceuticals
    • Consumer Healthcare
    • Core Therapeutic Areas
    • Innovation
    • Research & Development
    • Business Development Leaders
    • Pfizer Ventures
  • Health Professionals
  • Connect with Us
    • Email
    • FAQ
    • Privacy Policy (NEW)
    • YouTube
    • Twitter
    • Facebook
    • LinkedIn
    • Instagram
   
 
  • Your Health
    • Healthy Living
      • Brain & Nervous System
      • Cardiovascular Health
      • Cold & Flu
      • Digestive Health
      • Healthier Aging
      • Living Tobacco Free
      • Men’s Health
      • Mental Health
      • Nutrition & Fitness
      • Pediatric Health
      • Respiratory Health
      • Skin Health
      • Vaccines & Prevention
      • Women’s Health
    • Disease & Condition
      • Cancer
      • Cardiovascular Diseases & Conditions
      • Diabetes & Metabolic Disorders
      • Immune System Diseases & Conditions
      • Infections & Infectious Diseases
      • Neurological Diseases & Conditions
      • Menopause
      • Rare Disease
      • Vaccine-Related Conditions
      • Skin Diseases & Conditions
    • Managing your health
      • Caregiving
      • Evaluating Health Information
      • Tracking Your Health
      • Your Medicines
      • Health Literacy
    • Wellness
    • Hot Topics

      Hot Topics

      7_ways_you_can_help_someone_with_diabetes300x170.jpg 7 Ways You Can Help Someone With Diabetes
  • Our Science
    • Driven to Discover
    • Therapeutic Areas
      • Internal Medicine
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
    • Product Pipeline
    • Clinical Trials
      • What are Clinical Trials?
      • How Clinical Trials are Conducted
      • Find a trial
      • Clinical Innovation
      • Pediatric Research
      • Trial Data & Results
      • Post Marketing Commitments
      • Pediatric Trials
    • R&D Platforms
      • Biosimilars
      • Gene Therapy
      • Medicinal Sciences
      • Precision Medicine
    • Collaboration
      • Collaboration Ecosystem
      • Centers for Therapeutic Innovation
      • Competitive Grants
      • Compound Transfer Program
      • R&D Collaborations
    • Research sites
    • Hot Topics
      new_rna_technology300x170.jpg New RNA Technology Could Get the Flu Vaccine Right
       lbcentral_300x170.jpg Neuroscience Startups Awarded “Golden Tickets”
  • Our People
    • Meet The Experts
      • Scientists
      • Cardiovascular & Metabolic Disease
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Medical Professionals
    • The Journey
    • Leadership
      • Executives
      • Board Members
      • Company Fact Sheet
    • Diverse Perspectives
      • Diversity & Inclusion
      • Supplier Diversity
    • Hot Topics
      runner1_300x170.jpg Completing the NYC Marathon Was a Dream Come True
      my_sisters_breast_cancer_diagnosis300x170.jpg My Sister's Breast Cancer Diagnosis and What It Meant for Me
  • Our Purpose
    • Responsibility
      • Individual Voices
      • Building Healthcare Capacity
      • Expanding Access to Medicine
      • The Pfizer Foundation
      • Disaster Relief
      • Global Institutions and Partnerships
      • Reporting Trends and Progress
    • Protecting People and the Environment
      • Pfizer's Green Journey
      • Product Stewardship
      • EHS Governance
      • EHS Supply Chain
      • Key Performance Indicators
      • Health & Safety
    • Positions on Health Policies
      • Ready for Cures
      • How does Pfizer price medicines?
      • Value of Medicines
      • Policy Positions
    • Transparency
      • Working with Health Care Professionals
      • Code of Conduct
      • Corporate Compliance
      • Sales and Marketing Compliance
    • Patient Assistance Programs
    • Independent Grants
      • Investigator Sponsored Research
      • Quality Improvement
      • Independent Medical Education
      • Transparency in Grants
    • Contributions & Partnerships
      • Healthcare Charitable Contributions
      • Special Charity Events
      • Lobbying & Political Contributions
    • Hot Topics
      fighting_for_cures300x170.jpg Learn How Scientists are Fighting for Cures
    • Life In Focus
      • Putting Patients First
      • Engaging Patients
      • Fostering Meaningful Partnerships
      • Making a Difference for Patients
  • Our Products
    • Product listing
    • How drugs are made
      • Branded vs. Generic
      • Biologics & Biosimilars
      • Commitment to Quality
    • Upjohn
      • About Upjohn
      • Portfolio of Brands
      • Manufacturing Plants
      • UpJohn Leadership
    • Distributors
      • Pfizer Distributors
      • Greenstone Distributors
    • Medicine Safety
      • Reporting Adverse Events
      • Making Good Treatment Choices
      • Partnering With Patients
      • Health Literacy
      • Medicine Safety Tips for Patients
      • Counterfeiting
      • Unused Medicines
    • Material Safety Data Sheets
    • Medical Information Contacts
    • Hot Topics
      Universal vs. Single Payer Healthcare
      Counterfeit Medicines - Is The Threat Real Or Fake Counterfeit Medicines - Is The Threat Real Or Fake

Compassionate Use of Unapproved Investigational Product

Policy on Investigational or Unlicensed Product Use Outside of a Clinical Trial

Effective October 1, 2015

The purpose of this policy is to describe the requirements for compassionate access to Pfizer investigational or unlicensed products to patients outside of a clinical study.

Pfizer development resources are focused on conducting clinical studies required by regulatory authorities to fully answer important scientific questions about the potential risks and benefits of our investigational products, and to obtain regulatory approval.

Pfizer is committed to making investigational or unlicensed products available to seriously ill patients who have exhausted other treatment options.  A treating physician, who is able to comply with the requirements that are stated in this document, may request information about how to apply for access to Pfizer’s investigational products by contacting Medical Information at www.pfizermedicalinformation.com .

This policy applies to:

  • Compassionate access to a Pfizer investigational product that is not approved for any purpose in the country from which the request is intended to be used. This also includes the time period between regulatory approval of an investigational product and its commercial availability in a country.
  • The use of a Pfizer unlicensed product which is not approved for the indication requested in the country where the product is intended to be used.

This policy generally does not apply to requests for unapproved new dosage form versions of an approved product (e.g., a request for a liquid formulation of a product that is already approved in a solid oral dosage form). However, decisions relating to such requests are governed by the same considerations as those presented in this policy in accordance with applicable legal/regulatory requirements and are evaluated on a case-by-case basis.

Top

1. POLICY STATEMENTS

  • Any use of a Pfizer investigational product outside a clinical study or unlicensed Pfizer product in a country must be in accordance with local laws and regulations governing such programs, including Pfizer policies and procedures.
  • In general, where permitted by local regulation, the investigational product supplied via compassionate access may no longer be provided by Pfizer when it becomes available via the local healthcare system.

Top

1.1. Patient Eligibility Criteria

To be eligible for access to an investigational or unlicensed product, patients must meet the following criteria:

  1. Suffer from a serious or immediately life-threatening disease or condition;
  2. Have undergone appropriate standard treatments without success and no comparable or satisfactory alternative treatment/prophylaxis vaccine is available or exists to diagnose, monitor or treat the disease or condition;
  3. Are ineligible for participation in any ongoing clinical study of the investigational product, which includes lack of access due to geographic limitations;
  4. Meet any other pertinent medical criteria for access to the investigational or unlicensed product, as established by the Pfizer clinical or medically responsible individual.

Top

1.2. Investigational Product Criteria

In addition to the patient eligibility requirements, the investigational product must meet the following criteria:

  1. The product is under investigation in one or more clinical studies.
  2. There is sufficient evidence to expect that the investigational product will have an acceptable safety profile for the intended patient population.
    • Alternatively, for molecularly targeted agents, there must be compelling biological rationale for that disease coupled with adequate human clinical data to support an assessment that the potential patient benefit justifies the potential risks of the treatment use, and those potential risks are not unreasonable in the context of the disease or condition to be treated.
  3. The provision of the investigational product will not interfere with or compromise the clinical development of the product.
    • Adequate supply of the investigational product exists to perform necessary clinical studies in addition to provide access to patients who do not have alternative treatment options.

Top

1.3. Treating Physician Criteria and Responsibilities

The physician(s) attending to the patient(s) who is/are receiving an investigational or unlicensed product through compassionate use access is (are) properly licensed and fully qualified to administer the product.

The physician must agree in writing to comply with:

  1. Any applicable country-specific legal and regulatory requirements related to providing an investigational or unlicensed product under compassionate access; and

  2. Any Pfizer requirements in terms of medical criteria, safety reporting, drug supply/use, and protection of intellectual property.

Top

 

Related articles

Our Purpose
fighting_for_cures300x170.jpg
Learn How Scientists are Fighting for Cures
Your Health
7_ways_you_can_help_someone_with_diabetes300x170.jpg
7 Ways You Can Help Someone with Diabetes
Your Health
straight_talking_about_vaping300x170.jpg
Straight Talk about Vaping
Your Health
understanding_depression300x170.jpg
Understanding Depression
Your Health
4 Foods That May Increase Osteoporosis Risk
4 Foods That May Increase Osteoporosis Risk
Our Purpose
partnering_to_help_protect_300x170.jpg
Helping to Protect Babies in Underserved...
Our Purpose
IFRC_Individual_Voices_Article_Image300x170.jpg
Empowering Healthy Aging in Communities...
Our Science
new_rna_technology300x170.jpg
New RNA Technology Could Get the Flu Vaccine...
Your Health
selfie300x170.jpg
5 Lessons We've Learned about Aging in...
Your Health
park300x170.jpg
5 Tips to Better Cope with Prostate Cancer
Your Health
the_power_of_family300x170.jpg
Learn about the Power of Family During World...
Our People
runner1_300x170.jpg
For Pfizer's Gertjan Ophorst,...
Our Purpose
ICFP_IVArticle_HeroTileImage_300x170.jpg
Celebrating the Catalytic Power of...
Your Health
identifying-gaps_300x170.jpg
Matter of Moments: Recognizing AFib-Stroke...
Our Purpose
The Value of Targeted Therapies in Kidney Cancer
The Value of Targeted Therapies in Kidney...
Our Purpose
vom_chronic_inflammation300x170.jpg
Chronic Inflammation and Inflammatory Disease
Our Purpose
Value of Rheumatoid Arthritis Treatment
Our Purpose
Value of Medicines: Psoriasis
The Value of Medicines for Psoriasis
Our Purpose
The Value of OTC Medicines
The Value of OTC Medicines
Our Purpose
The Value of Medicines for Healthy Aging
The Value of Medicines for Healthy Aging
Our Purpose
The Value of Medicines in Offsetting Healthcare Costs
The Value of Medicines in Offsetting...
  • Footer Left Menu
    • YOUR HEALTH
      • Healthy Living
      • Disease & Conditions
      • Managing Your Health
    • Our Science
      • Therapeutic Areas
      • Product Pipeline
      • Clinical Trials
      • R&D Platforms
      • Collaboration
      • Research Sites
    • OUR PEOPLE
      • Meet The Experts
      • The Journey
      • Leadership
      • Diverse Perspectives
    • OUR PURPOSE
      • Responsibility
      • Positions on Health Policies
      • Transparency
      • Contributions & Partnerships
    • OUR PRODUCTS
      • Product Listing
      • How Drugs are Made
      • Distributors
      • Material Safety Data Sheets
      • Global Product Information Contacts
  • Footer Right Menu
    • Section 1
      • Career-seekers
      • Investors
      • News & Media
      • Partners
    • Section 2
      • Health Professionals
      • Business to Business
      • Change Country
      • Sitemap
    • Section 3
      • Twitter
      • Facebook
      • Linkedin
      • Instagram
      • Youtube
    • Section 4
      • Contact Us
      • Terms of Use
      • Privacy Policy (NEW)
Copyright © 2002-2018 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.